In a rapidly evolving global landscape, seasoned economist Andrew Freris highlights an interesting shift in investment horizons. Traditional safe havens like gold and silver are losing some of their luster, making way for sectors and regions that [...]
The much-anticipated initial public offering (IPO) of Lenskart, India's leading eyewear retailer, has turned out to be a massive financial win for early investors—most notably the PI Opportunities Fund, backed by veteran investor Azim Premji. The fund [...]
Adani Energy Solutions has become a focal point for investors following its announcement of a 21% year-on-year decline in consolidated net profit for the second quarter of fiscal year 2026. The company reported a net profit of [...]
The Indian rupee recently hit a fresh record low of 88.24 against the US dollar, marking a significant depreciation and underlining ongoing pressures in the currency markets. This decline comes amid continued strong demand for the dollar, [...]
If you’ve been tracking Tata Motors shares recently and noticed something odd, you’re not alone. Many investors have found that Tata Motors Commercial Vehicle shares, which were newly issued following a corporate restructuring, aren’t showing up in [...]
Godrej Properties, one of India's leading real estate developers, is gearing up for a major business leap with a new luxury housing project in Worli, Mumbai. The company is eyeing revenue generation of over Rs 10,000 crore [...]
Vodafone Idea Ltd (Vi), a major player in the Indian telecom market, saw its shares jump more than 13% from the day’s low, injecting fresh optimism into the stock. This surge was triggered after the Supreme Court [...]
In a groundbreaking move towards digital finance, Kyrgyzstan has officially launched its national stablecoin, marking a significant step in the country's cryptocurrency and digital currency evolution. This initiative is being undertaken in partnership with Binance, one of [...]
In an impressive milestone for Japan’s stock market, the Nikkei 225 index surged past the 50,000 mark for the first time ever. This landmark achievement has investors buzzing, primarily driven by renewed optimism surrounding government stimulus measures [...]
Dr. Reddy's Laboratories (DRL), a prominent player in the pharmaceutical industry, has been witnessing a notable slowdown in sales of its generic version of Revlimid (lenalidomide), a popular cancer drug, especially in the highly competitive US market. [...]